908 Devices Inc. Common Stock MASS
i
Market dataready · fetched 2026-11-11T14:02:44.684Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-10T21:00:00.734308264Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-11T14:02:44.313991+00:00
908 Devices Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 15.32 | 253.4% | 57.2% | 6.45 | 326.8% | 39.6% |
| 25Δ | 12.75 | 182.7% | 31.4% | 7.09 | 282.2% | 33.3% |
| 30Δ | 12.15 | 183.7% | 27.0% | 7.73 | 237.5% | 27.0% |
| 35Δ | 11.76 | 192.8% | 24.8% | 8.37 | 192.8% | 20.8% |
| 40Δ | 11.36 | 202.0% | 22.6% | 9.01 | 148.1% | 14.5% |
| 45Δ | 10.97 | 211.1% | 20.4% | 9.66 | 103.5% | 8.2% |
| 50Δ | 10.58 | 220.2% | 18.2% | 10.45 | 91.0% | 4.7% |
| 55Δ | 10.19 | 229.4% | 16.0% | 11.43 | 115.8% | 4.4% |
| 60Δ | 9.72 | 238.4% | 13.9% | 12.41 | 140.6% | 4.1% |
| 65Δ | 9.19 | 247.5% | 12.0% | 13.38 | 165.4% | 3.7% |
| 70Δ | 8.66 | 256.5% | 10.1% | 14.36 | 190.2% | 3.4% |
| 75Δ | 8.12 | 265.5% | 8.2% | 15.33 | 215.0% | 3.1% |
| 80Δ | 7.59 | 274.5% | 6.2% | 16.31 | 239.8% | 2.8% |
20Δ
- Pseudo strike
- 15.32
- IV
- 253.4%
- B/E move
- 57.2%
- Pseudo strike
- 6.45
- IV
- 326.8%
- B/E move
- 39.6%
25Δ
- Pseudo strike
- 12.75
- IV
- 182.7%
- B/E move
- 31.4%
- Pseudo strike
- 7.09
- IV
- 282.2%
- B/E move
- 33.3%
30Δ
- Pseudo strike
- 12.15
- IV
- 183.7%
- B/E move
- 27.0%
- Pseudo strike
- 7.73
- IV
- 237.5%
- B/E move
- 27.0%
35Δ
- Pseudo strike
- 11.76
- IV
- 192.8%
- B/E move
- 24.8%
- Pseudo strike
- 8.37
- IV
- 192.8%
- B/E move
- 20.8%
40Δ
- Pseudo strike
- 11.36
- IV
- 202.0%
- B/E move
- 22.6%
- Pseudo strike
- 9.01
- IV
- 148.1%
- B/E move
- 14.5%
45Δ
- Pseudo strike
- 10.97
- IV
- 211.1%
- B/E move
- 20.4%
- Pseudo strike
- 9.66
- IV
- 103.5%
- B/E move
- 8.2%
50Δ
- Pseudo strike
- 10.58
- IV
- 220.2%
- B/E move
- 18.2%
- Pseudo strike
- 10.45
- IV
- 91.0%
- B/E move
- 4.7%
55Δ
- Pseudo strike
- 10.19
- IV
- 229.4%
- B/E move
- 16.0%
- Pseudo strike
- 11.43
- IV
- 115.8%
- B/E move
- 4.4%
60Δ
- Pseudo strike
- 9.72
- IV
- 238.4%
- B/E move
- 13.9%
- Pseudo strike
- 12.41
- IV
- 140.6%
- B/E move
- 4.1%
65Δ
- Pseudo strike
- 9.19
- IV
- 247.5%
- B/E move
- 12.0%
- Pseudo strike
- 13.38
- IV
- 165.4%
- B/E move
- 3.7%
70Δ
- Pseudo strike
- 8.66
- IV
- 256.5%
- B/E move
- 10.1%
- Pseudo strike
- 14.36
- IV
- 190.2%
- B/E move
- 3.4%
75Δ
- Pseudo strike
- 8.12
- IV
- 265.5%
- B/E move
- 8.2%
- Pseudo strike
- 15.33
- IV
- 215.0%
- B/E move
- 3.1%
80Δ
- Pseudo strike
- 7.59
- IV
- 274.5%
- B/E move
- 6.2%
- Pseudo strike
- 16.31
- IV
- 239.8%
- B/E move
- 2.8%
Options history
Table
| Date | IV (%) |
|---|---|
| 80.95% | |
| 68.42% | |
| 72.53% | |
| 77.10% | |
| 74.07% | |
| 76.31% | |
| 79.94% | |
| 72.12% | |
| 71.87% | |
| 92.42% |
Medical Devices
MBOT
Microbot Medical Inc., a preclinical medical device company, researches, designs and develops micro-robotic-assisted medical technologies targeting the minimally invasive surgery…
More →MDT
Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in…
More →MXCT
MaxCyte Inc. (MXCT) is a leader in cell-engineering, renowned for its innovative Flow Electroporation® technology that enables efficient and scalable delivery of nucleic acids and…
More →NEOG
Neogen Corporation, develops, manufactures and markets various products for food and animal safety worldwide. The company is headquartered in Lansing, Michigan.
More →NNOX
Nano-X Imaging Ltd., a development-stage company, develops, produces and markets digital X-ray source technology for the medical imaging industry globally. The company is…
More →NPCE
Description unavailable
More →